Related references
Note: Only part of the references are listed.Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults
Ivonne Sluijs et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Interpreting weight losses from lifestyle modification trials: using categorical data
J. G. Christian et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Milk Enriched with Conjugated Linoleic Acid Fails to Alter Blood Lipids or Body Composition in Moderately Overweight, Borderline Hyperlipidemic Individuals
Sudha Venkatramanan et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2010)
The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese
C. Syvertsen et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
The epidemiology of obesity
Cynthia L. Ogden et al.
GASTROENTEROLOGY (2007)
The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain
A. C. Watras et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese
Jean-Michel Gaullier et al.
BRITISH JOURNAL OF NUTRITION (2007)
Conjugated linoleic acid intake in humans: A systematic review focusing on its effect on body composition, glucose, and lipid metabolism
J. Salas-Salvado et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2006)
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study
S Yusuf et al.
LANCET (2005)
Safety profile of conjugated linoleic acid in a 12-month trial in obese humans
LD Whigham et al.
FOOD AND CHEMICAL TOXICOLOGY (2004)
Influence of conjugated linoleic acids on body composition and selected serum and endocrine parameters in resistance-trained athletes
C von Loeffelholz et al.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY (2003)
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
DG Altman et al.
ANNALS OF INTERNAL MEDICINE (2001)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher et al.
LANCET (2001)
Statistical considerations in the intent-to-treat principle
JM Lachin
CONTROLLED CLINICAL TRIALS (2000)
Share Paper
